K Pharma: Financial results announcement for the second quarter (interim period) of December 2024, based on Japanese accounting standards (non-consolidated).
K Pharma: Financial results briefing materials for the second quarter (interim period) of December 2024.
K Pharma: Half Year Report - Term 8 (2024/01/01 - 2024/12/31)
K Pharma: Confirmation letter
K PHARMA: Presentation of financial results for the 1st quarter of the fiscal year ending 2024/12
K PHARMA: Quarterly Report - Eighth Quarter 1 (2024/01/01 - 2024/03/31)
K PHARMA: Confirmation letter
K PHARMA: Summary of financial results for the 1st quarter of the fiscal year ending 2024/12 [Japanese GAAP] (unconsolidated)
K PHARMA: Extraordinary Report
K Pharma: Confirmation
K Pharma: Financial Report - 7th Term (2023/01/01 - 2023/12/31)
K Pharma: Financial results briefing materials for the fiscal year ending 2023/12
K Pharma: Notice regarding the recording of non-operating expenses and extraordinary losses and differences between full-year earnings forecasts and actual values for the fiscal year ending 2023/12
K Pharma: Summary of financial results for the fiscal year ending 2023/12 [Japanese GAAP] (unconsolidated)
K Pharma: Financial results briefing materials for the 3rd quarter of the fiscal year ending 2023/12
K Pharma: Summary of financial results for the 3rd quarter of the fiscal year ending December 31, 2023 [Japanese GAAP] (unconsolidated)
K Pharma: Confirmation letter
K Pharma: Quarterly Report - 7th 3rd Quarter (2023/07/01 - 2023/09/30)
K Pharma: Extraordinary Report
No Data